Archives202520242023202220212020201920182017201620152014201320122011 July 29, 2015Richard Warr Read More July 27, 2015ClinicalTrials.Gov registration of LUPUZOR™ Pivotal Phase III Trial Read More July 25, 2015Term Sheet signed with US Investor to secure up to US$14 Million Funding For LUPUZOR™ Read More June 25, 2015Lupuzor’s Founder, Dr Slyviane Muller – Awarded Medal of Innovation from CNRS for Lupuzor™ Read More May 29, 2015ANNUAL GENERAL MEETING: 2015 Read More May 07, 2015Notice of Annual General Meeting: 29 May 2015 Read More April 30, 2015Preliminary Results Announcement for the year ended 31 December 2014 Read More April 30, 2015Dr Stéphane Méry Appointed as Non-Executive Director Read More February 11, 2015Cancer Update: IPP-204106 Read More January 27, 2015Advance Assurance Received from H M Revenue and Customs Regarding “Enterprise Investment Scheme” Status Read More January 22, 2015Landmark Collaboration Agreement & Commencement of Pivotal Phase III Lupuzor™ Study with Simbec-Orion Read More October 21, 2014ImmuPharma awarded €400,000 grant in support of its pioneering research in the Bordeaux region of France Read More 1…181920212223
July 25, 2015Term Sheet signed with US Investor to secure up to US$14 Million Funding For LUPUZOR™ Read More
June 25, 2015Lupuzor’s Founder, Dr Slyviane Muller – Awarded Medal of Innovation from CNRS for Lupuzor™ Read More
January 27, 2015Advance Assurance Received from H M Revenue and Customs Regarding “Enterprise Investment Scheme” Status Read More
January 22, 2015Landmark Collaboration Agreement & Commencement of Pivotal Phase III Lupuzor™ Study with Simbec-Orion Read More
October 21, 2014ImmuPharma awarded €400,000 grant in support of its pioneering research in the Bordeaux region of France Read More
